Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY - USD ($)
$ in Thousands
Total
Stock Purchase Agreement
Follow On Offering
Private Placement
Common Stock
Common Stock
Stock Purchase Agreement
Common Stock
Follow On Offering
Common Stock
Private Placement
Additional Paid‑In Capital
Additional Paid‑In Capital
Stock Purchase Agreement
Additional Paid‑In Capital
Follow On Offering
Additional Paid‑In Capital
Private Placement
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at Dec. 31, 2017 $ 65,324       $ 26       $ 220,606       $ (42) $ (155,266)
Balance (in shares) at Dec. 31, 2017         26,423,375                  
Exercise of stock options 242               242          
Exercise of stock options, Shares         58,773                  
Issuance of common stock, net of issuance costs   $ 7,648 $ 42,664 $ 1,380   $ 1 $ 5     $ 7,647 $ 42,659 $ 1,380    
Issuance of common stock, net of costs and fees (in shares)           793,021 4,816,753 144,505            
Stock-based compensation expense 1,696               1,696          
Unrealized holding gains on marketable securities 8                       8  
Net loss (14,463)                         (14,463)
Balance at Mar. 31, 2018 104,499       $ 32       274,230       (34) (169,729)
Balance (in shares) at Mar. 31, 2018         32,236,427                  
Balance at Dec. 31, 2017 65,324       $ 26       220,606       (42) (155,266)
Balance (in shares) at Dec. 31, 2017         26,423,375                  
Net loss (62,300)                          
Balance at Dec. 31, 2018 $ 78,586       $ 34       296,100       (3) (217,545)
Balance (in shares) at Dec. 31, 2018 33,765,864       33,765,864                  
Exercise of stock options $ 3               3          
Exercise of stock options, Shares 1,077       1,077                  
Stock-based compensation expense $ 1,879               1,879          
Unrealized holding gains on marketable securities 11                       11  
Net loss (16,461)                         (16,461)
Balance at Mar. 31, 2019 $ 64,018       $ 34       $ 297,982       $ 8 $ (234,006)
Balance (in shares) at Mar. 31, 2019 33,766,941       33,766,941